Benjamin Prosser

Associate Professor

View Lab Website Arrow Icon
215-746-1488
bpros@pennmedicine.upenn.edu

726 Clinical Research Building

415 Curie Boulevard

Philadelphia, PA 19104

Research Description

The Prosser Lab - developing new therapies for the heart and brain.
(Simple, right?)  

Our lab interrogates the forces of the heart – the mechanisms that control how a heart cell generates force, and how force itself feeds back to regulate cell function and form. We leverage cellular biophysics and engineering, super-resolution imaging and cardiology to tackle the fundamental challenges of the mechanobiology of the heart. Our goal is to provide transformative insight into how the heart beats, and to inform new therapies for the treatment of heart disease.  

The diagnosis of Dr. Prosser's daughter with STXBP1 encephalopathy also spurred the generation of a new therapeutic arm in the lab for neurological applications. We are developing novel, antisense oligonucleotide based therapies for the treatment of inherited neurodevelopmental disorders, such as those caused by mutations in STXBP1. 

Diversity & Inclusion Initiatives

  • Mentor and Lecturer, Penn SUIP and PREP programs
  • Host of Workshop in Cell Biology for STEM undergrads from underrepresented communities
  • Member, Admissions committee for Cell Biology, Physiology and Metabolism (CPM) graduate group, which facilitates recruitment of diversity trainees. 

Degrees & Education

BS, Wake Forest University, 2005

PhD, University of Maryland School of Medicine, 2009

Honors & Awards

2011 Outstanding Postdoctoral Scholar Award

2017 Linda Pechenik Montague Investigator Award

2017 Outstanding Early Career Investigator Award, American Heart Association (AHA)

2018 Outstanding Alumnus Award, University of Maryland School of Medicine

2021 Lead Coordinator, Leducq Transatlantic Network of Excellence

Other Perelman School of Medicine Affiliations

Pennsylvania Muscle Institute

Cardiovascular Institute

Professional Affiliations

Biophysical Society

Cardiac Muscle Society

American Heart Association

STXBP1 Foundation Scientific Advisory Board

Recent Publications
November 3, 2021
Truncated titin proteins in dilated cardiomyopathy
Benjamin Prosser, Ph.D., Kenneth B. Margulies, M.D., Zoltan Pierre Arany
QUENTIN MCAFEE, CHRISTINA YINGXIAN CHEN, YIFAN YANG, MATTHEW A. CAPORIZZO, MICHAEL MORLEY, APOORVA BABU, SUNHYE JEONG, JEFFREY BRANDIMARTO, KENNETH C. BEDIJR, EMILY FLAM, JOSEPH CESARE, THOMAS P. CAPPOLA, KENNETH MARGULIES, BENJAMIN PROSSER AND ZOLT ARANY/ DOI: 10.1126/scitranslmed.abd7287
Article Arrow Icon
November 9, 2023
Truncated titin protein in dilated cardiomyopathy incorporates into the sarcomere and transmits force
Zoltan Pierre Arany, Benjamin Prosser, Ph.D.
Quentin McAfee, Matthew A Caporizzo, Keita Uchida , Kenneth C Bedi Jr, Kenneth B Margulies, Zolt Arany, Benjamin L Prosser DOI: 10.1172/JCI170196
Article Arrow Icon
April 19, 2022
The microtubule cytoskeleton in cardiac mechanics and heart failure
Benjamin Prosser, Ph.D.
Caporizzo MA, Prosser BL. DOI: 10.1038/s41569-022-00692-y
Article Arrow Icon
February 10, 2022
Cardiomyocyte Microtubules: Control of Mechanics, Transport, and Remodeling
Benjamin Prosser, Ph.D.
Uchida K, Scarborough EA, Prosser BL. DOI: 10.1146/annurev-physiol-062421-040656
Article Arrow Icon
March 11, 2021
Microtubules orchestrate local translation to enable cardiac growth
Benjamin Prosser, Ph.D.
Scarborough EA, Uchida K, Vogel M, Erlitzki N, Iyer M, Phyo SA, Bogush A, Kehat I, Prosser BL. - DOI: 10.1038/s41467-021-21685-4
Article Arrow Icon
January 26, 2021
Pathogenic LMNA variants disrupt cardiac lamina-chromatin interactions and de-repress alternative fate genes. Cell Stem Cell
Benjamin Prosser, Ph.D.
Shah PP, Lv W, Rhoades JH, Poleshko A, Abbey D, Caporizzo MA, Linares-Saldana R, Heffler JG, Sayed N, Thomas D, Wang Q, Stanton LJ, Bedi K, Morley MP, Cappola TP, Owens AT, Margulies KB, Frank DB, Wu JC, Rader DJ, Yang W, Prosser BL, Musunuru K, Jain R. - DOI: 10.1016/j.stem.2020.12.016
Article Arrow Icon
January 14, 2021
Tubulin Detyrosination: An Emerging Therapeutic Target in Hypertrophic Cardiomyopathy
Benjamin Prosser, Ph.D.
Margulies KB, Prosser BL - DOI: 10.1161/CIRCHEARTFAILURE.120.008006
Article Arrow Icon
ALL Publications Arrow Icon